News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Ondine Biomedical Inc. Announces HCA to invest US$4 million in Ondine
Ondine Biomedical Inc. announces US$4 million equity investment from hInsight-NX, LLC, a subsidiary of HCA Healthcare, Inc., for antimicrobial treatments. Private Placement issued 38,033,412 common shares. Funds to support strategic objectives until early Q4 2025 -